These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29945333)

  • 21. Unexpected Non-Maternally Derived Anti-PP1P
    Reeves HM; Cary V; Mino MA; McGrath C; Westra JA; Piccone C; Downes KA
    J Pediatr; 2017 Feb; 181():302-305. PubMed ID: 27852457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haemolysis after treatment with intravenous immunoglobulin due to anti-A.
    Morgan S; Sorensen P; Vercellotti G; Zantek ND
    Transfus Med; 2011 Aug; 21(4):267-70. PubMed ID: 21605202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of the red cell alloantibody anti-E in an 11-week-old infant.
    DePalma L; Criss VR; Roseff SD; Luban NL
    Transfusion; 1992 Feb; 32(2):177-9. PubMed ID: 1542926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of IgG alloantibodies in patients with high-titer IgM cold agglutinins by serum/plasma affinity chromatography.
    Stahl D; Kreft H; Hack H; Schraven B; Roelcke D
    Beitr Infusionsther Transfusionsmed; 1997; 34():176-9. PubMed ID: 9356670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early primary immune response against erythrocytes: a case report.
    Albiero AL; Novaretti MC; Llacer PE; Chamone DA
    Transfus Med; 2003 Apr; 13(2):93-7. PubMed ID: 12694554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-KANNO: a novel alloantibody against a red cell antigen of high frequency.
    Kawabata K; Uchikawa M; Ohto H; Yasuda H; Tsuneyama H; Tsuchida H; Ito S
    Transfus Med Rev; 2014 Jan; 28(1):23-8. PubMed ID: 24485899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The routine use of Rh-negative reagent red cells for the identification of anti-D and the detection of non-D red cell antibodies.
    Shulman IA; Calderon C; Nelson JM; Nakayama R
    Transfusion; 1994 Aug; 34(8):666-70. PubMed ID: 8073481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
    Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
    Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study.
    Azarkeivan A; Ansari S; Ahmadi MH; Hajibeigy B; Maghsudlu M; Nasizadeh S; Shaigan M; Toolabi A; Salahmand M
    Pediatr Hematol Oncol; 2011 Sep; 28(6):479-85. PubMed ID: 21854216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Red blood cell alloantibodies after transfusion: factors influencing incidence and specificity.
    Schonewille H; van de Watering LM; Loomans DS; Brand A
    Transfusion; 2006 Feb; 46(2):250-6. PubMed ID: 16441603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a single allogeneic pregnancy on the alloantibody response to a subsequent transfusion in rats.
    Cunningham C; Power DA; Catto GR
    Transplant Proc; 1987 Feb; 19(1 Pt 1):567. PubMed ID: 3274822
    [No Abstract]   [Full Text] [Related]  

  • 32. Red-blood-cell alloimmunization and number of red-blood-cell transfusions.
    Zalpuri S; Zwaginga JJ; le Cessie S; Elshuis J; Schonewille H; van der Bom JG
    Vox Sang; 2012 Feb; 102(2):144-9. PubMed ID: 21729098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatments for hematologic malignancies in contrast to those for solid cancers are associated with reduced red cell alloimmunization.
    Evers D; Zwaginga JJ; Tijmensen J; Middelburg RA; de Haas M; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; van der Bom JG
    Haematologica; 2017 Jan; 102(1):52-59. PubMed ID: 27634204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of mediators of systemic inflammatory response syndrome in the course of a severe delayed hemolytic transfusion reaction caused by anti-D.
    von Zabern I; Ehlers M; Grunwald U; Mauermann K; Greinacher A
    Transfusion; 1998 May; 38(5):459-68. PubMed ID: 9633559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Red cell alloimmunisation in oncology patients: A study from eastern India.
    Dhar S; Basu S
    Transfus Apher Sci; 2015 Jun; 52(3):345-9. PubMed ID: 25818996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of red blood cell alloantibody detection duration: analysis of multiply alloimmunized patients supports peritransfusion factors.
    Noiret L; Slater A; Higgins JM
    Transfusion; 2017 Aug; 57(8):1930-1937. PubMed ID: 28639314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alloimmunization to red cells in thalassemics: emerging problem and future strategies.
    Gupta R; Singh DK; Singh B; Rusia U
    Transfus Apher Sci; 2011 Oct; 45(2):167-70. PubMed ID: 21856231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A retrospective study to determine the risk of red cell alloimmunization and transfusion during pregnancy.
    Heddle NM; Klama L; Frassetto R; O'Hoski P; Leaman B
    Transfusion; 1993 Mar; 33(3):217-20. PubMed ID: 8438222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute extravascular hemolytic transfusion reaction due to anti-Kpa antibody missed by electronic crossmatch.
    Padmore R; Berardi P; Erickson K; Desjardins D; Giulivi A; Tokessy M; Neurath D; Saidenberg E
    Transfus Apher Sci; 2014 Oct; 51(2):168-71. PubMed ID: 25175412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple red cell alloantibodies, including anti-Dib, after allogeneic ABO-matched peripheral blood progenitor cell transplantation.
    Zupańska B; Zaucha JM; Michalewska B; Malinowska A; Brojer E; Hellmann A
    Transfusion; 2005 Jan; 45(1):16-20. PubMed ID: 15647013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.